ClinicalTrials HQ

A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.

A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.

Recruiting · NCT07470853 · Registry updated 2026-08-18
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder, uterine disorderRecruitingPhase 12026-08-18NCT07470853

2 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Catalyst Pharmaceutical Research2
Whitehawk Therapeutics, Inc.2

12 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Atrium Health - Wake ForestCharlotteUnited States1
Karmanos Cancer CenterDetroitUnited States16
Memorial Sloan Kettering Cancer CenterNew YorkUnited States2
Ohio State University Wexner Medical CenterColumbusUnited States36
SCRI - Florida Cancer SpecialistsSarasotaUnited States2
SCRI - Mary Crowley Cancer ResearchDallasUnited States1
SCRI - Sydney Kimmel Cancer Center - Jefferson HealthPhiladelphiaUnited States1
St. Francis Medical Center (OSF Healthcare)PeoriaUnited States2
START - Los AngelesLos AngelesUnited States2
Start - NyLong Island CityUnited States1
START MountainSalt Lake CityUnited States1
University of Arkansas - Winthrop P. Rockefeller Cancer InstituteLittle RockUnited States2